Skip to main content
SpringerLink
Log in
Book cover

Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders pp 159–171Cite as

Health Related Quality of Life in Subjects at Risk for a First Episode Of Psychosis

  • Chapter

  • 2009 Accesses

Abstract

To date no data on health related quality of life (HRQL) in subjects at risk for a first episode of psychosis compared with first episode schizophrenia patients (FE) or healthy controls (HC) is available, although the concept of HRQL is of growing relevance in schizophrenia research. Therefore 45 subjects in a putatively early initial prodromal state (EIPS), 40 FE and 45 HC were assessed for demographics, psychopathology and HRQL as measured by the self-rating instrument Modular System for Quality of Life. Results indicated that on a descriptive level in most life areas HC experienced the highest HRQL scores followed in hierarchical order by EIPS and FE. EIPS and FE experienced significantly lower HRQL than HC in 5 and 6 of 7 HRQL domains. When comparing EIPS and FE, EIPS experienced a significantly lower HRQL level in affective HRQL. HRQL ratings in EIPS were negatively correlated with joining school or work and higher positive prodromal symptom scores. In FE HRQL scores were negatively correlated with age and depression. The major finding from the study is that HRQL in subjects at risk for a first episode of psychosis is substantially reduced when compared with HC. Thus, HRQL maybe already reduced prior to the onset of first positive schizophrenia symptoms. These data support the notion that subjects at risk for a first episode of psychosis constitute a clinical population in which further service and intervention research is indicated

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Mueser KT, McGurk SR, Schizophrenia. Lancet. 2000; 363: 2063–72.

    Article  Google Scholar 

  2. Terkelsen KG, Menikoff A. Measuring costs of schizophrenia: implications for the post-institutional era in the US. Pharmacoeconomics 1995; 8: 199–222.

    Article  PubMed  CAS  Google Scholar 

  3. Geller JL, An historical perspective on the role of state hospitals viewed form the “revolving door”, Am J Psychiatry 1992; 149: 1526–33.

    Google Scholar 

  4. Rice DP. Economic burden of mental disorders in the United States. Economics Neuroscience 1999; 1: 40–44.

    Google Scholar 

  5. Murray CJL, Lopez AD, eds. The global burden of disease and injury series, vol. 1: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge MA: Harvard University Press, 1996.

    Google Scholar 

  6. US Institute of Medicine. Neurological, psychiatric, and developmental disorders: meeting the challenges in the developing world. Washington, DC: National Academy of Sciences, 2001.

    Google Scholar 

  7. McGlashan TH, Johannessen JO (1996) Early detection and intervention in schizophrenia. Rationale. Schizophr Bull 22: 201–222.

    CAS  Google Scholar 

  8. Häfner, H., Riecher-Rössler, A., Maurer, K. et al., 1992. First onset and early symptomatology of schizophrenia. Eur. Arch. Psychiatry. Clin. Neurosci. 242, 109–118.

    Article  PubMed  Google Scholar 

  9. Häfner H, Nowotny B et al. (1995) When and how does schizophrenia produce social deficits? Eur Arch Psychiatry Clin Neurosci 246: 17–28

    Article  PubMed  Google Scholar 

  10. Norman RM, Malla AK (2001) Duration of untreated psychosis: a critical examination of the concept and its importance. Psychol Med 31(3): 381–400.

    Article  PubMed  CAS  Google Scholar 

  11. Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T (2005) Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Arch Gen Psychiatry 62(9): 975–983.

    Article  PubMed  Google Scholar 

  12. Pantelis C, Yücel M, Wood SJ, Velakoulis D, Sun D, Berger G, Stuart GW, Yung A, Phillips L, McGorry P (2005) Structural Brain Imaging Evidence for Multiple Pathological Processes at Different Stages of Brain Development in Schizophrenia. Schizophr Bull 31: 672–696.

    Article  PubMed  Google Scholar 

  13. Miller T.J., McGlashan T.H., Rosen J.L., Somjee L., Markovich P.J., Stein K., Woods S.W., 2002. Prospective diagnosis of the initial prodrome for schizophrenia based on the structured interview for prodromal syndromes: preliminary evidence of interrater reliability and predictive validity. Am. J. Psychiatry 159, 863–865.

    Article  PubMed  Google Scholar 

  14. Miller T.J., Zipursky R.B., Perkins D., Addington J., Woods S.W., Hawkins K.A., Hoffman R., Preda A., Epstein I., Addington D., Lindborg S., Marquez E., Tohen M., Breier A., McGlashan T.H., 2003. The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the’’prodromal’’ sample. Schizophr. Res. 61(1), 19–30.

    CAS  Google Scholar 

  15. Yung, A.R., Phillips, L.J., Yuen, H.P., Francey, S.M., McFarlane, C.A., Hallgren, M., McGorry, P.D., 2003. Psychosis prediction: 12-month follow up of a high-risk (’’prodromal’’) group. Schizophr. Res. 60(1), 21–23.

    Article  PubMed  Google Scholar 

  16. Yung, A.R., Phillips, L.J., Yuen, H.P., McGorry, P.D., 2004. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr. Res. 67, 131–142.

    Article  PubMed  Google Scholar 

  17. Klosterkotter, J., Hellmich, M., Steinmeyer, E.M., Schultze-Lutter, F., 2001. Diagnosing schizophrenia in the initial prodromal phase. Arch. Gen. Psychiatry 58, 158–164.

    Article  PubMed  CAS  Google Scholar 

  18. Bechdolf A, Veith V, Berning J, Stamm E, Janssen B, Wagner M, Klosterkötter J (2005a) Cognitive-behavioural therapy in the pre-psychotic phase. An exploratory study. Psychiatr Res 136 (2–3): 251–55.

    Article  Google Scholar 

  19. Bechdolf A, Ruhrmann S, Wagner M, Kuhn KU, Janssen B, Bottlender R, Wieneke A, Schultze-Lutter F, Maier W, Klosterkötter J (2005b) Interventions in the initial prodromal states of psychosis in Germany: Concept and recruitment. B J Psychiatry Suppl 48: S45–8.

    Article  Google Scholar 

  20. McGlashan TH, Zipursky RB perkins D, Addington J, Miller T, Woods SW et al. (2006) A randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis. Am J Psych 163(5): 790–99.

    Article  Google Scholar 

  21. McGorry P.D., Yung A.R., Phillips L.J. et al., 2002. Can first episode psychosis be delayed or prevented? A randomized controlled trial of interventions during the prepsychotic phase of schizophrenia and related psychosis. Arch. Gen. Psychiatry 59(10), 921–928.

    Article  PubMed  Google Scholar 

  22. Morrison A.P., French P., Walford L., Lewis S.W., Kilcommons A., Green J., Parker S., Bentall R. P., 2004. A randomised controlled trial of early detection and cognitive therapy for the prevention of psychosis in people at ultra-high risk. Br. J. Psychiatry 185, 291–7.

    Article  PubMed  Google Scholar 

  23. American Psychiatric Association, 1994. Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition). Washington, D.C.

    Google Scholar 

  24. Kohn, D., Niedersteberg, A., Wieneke, A., Bechdolf, A., Pukrop, R., Ruhrmann, S., Schultze-Lutter, F., Maier, W., Klosterkötter, J., 2004. Early course of illness in first episode schizophrenia with long duration of untreated illness - a comparative study. Fortschr. Neurol. Psychiatr. 72(2): 88–92.

    Article  PubMed  CAS  Google Scholar 

  25. Preda, A., Miller, T.J., Rosen, J.L., Somjee, L., McGlashan,T.H., Woods, S.W., 2002. Treatment histories of patients with a syndrome putatively prodromal to schizophrenia. Psychiatr. Serv. 53(3), 342–4.

    Article  PubMed  Google Scholar 

  26. Brockhaus-Dumke, A., Tendolka, I., Pukrop, R., Schultze-Lutter, F., Klosterkötter, J., Ruhrmann, S., 2005. Impaired mismatch negativity generation in prodromal subjects and patients with schizophrenia. Schizophr. Res. 73(2–3), 297–310.

    Article  PubMed  Google Scholar 

  27. Baker, F., Intagliata, J., 1982. Quality of life in the evaluation of community support systems. Evaluation and Program Planning 5, 69–79.

    Article  PubMed  CAS  Google Scholar 

  28. Lehman A.F., Ward N.C., Linn L.S., 1982. Chronic metal patients: the quality of life issue. Am. J. Psychiatry, 139(10), 1271–76.

    PubMed  CAS  Google Scholar 

  29. Ritsner, M. (2006) The distress/protection vulnerability model of quality of life impairment in mental disorders. Current evidence and future research directions (chapter one, this book).

    Google Scholar 

  30. Pukrop, R., Schlaak, V., Möller-Leimkühler, A.M., Albus, M., Czernik, A., Klosterkötter, J., Möller, H.J., 2003. Reliability and validity of quality of life assessed by the short-form 36 and the Modular System for Quality of Life in patients with schizophrenia and patients with depression. Psychiatr. Res. 119, 63–79.

    Article  Google Scholar 

  31. Ritsner, M., Modaj, I., Endicott, J., Rivkin, O., Nechamkin, Y., Barak, P., Goldin, V., Ponizovsky, A., 2000. Differences in quality of life domains and psychopathologic and psychosocial factors in psychiatric patients. J. Clin. Psychiatry. 6(11), 880–89.

    Article  Google Scholar 

  32. Atkinson, M., Zibin, S., Chuang, H., 1997. Characterizing quality of life among patients with chronic mental illness: a critical examination of the self-report methodology. Am J Psychiatry. 154, 99–105.

    PubMed  CAS  Google Scholar 

  33. Browne, S., Roe, M., Lane, A., Gervin, M., Morris, M., Kinsella, A., Larkin, C., O’Callagahn, E., 1996. Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia. Acta. Psychiatr. Scand. 94, 118–124.

    PubMed  CAS  Google Scholar 

  34. Kaiser, W., Priebe, S., Hoffmann, K., Isermann, M., 2000. Profiles of subjective quality of life in schizophrenic in- and out-patient samples. Psychiatry Res. 66, 153–166.

    Article  Google Scholar 

  35. Andrews, F.M., Whitey, S.B., 1978. Social indicators of well-being. Americans’ perceptions of life quality. Plenum, New York.

    Google Scholar 

  36. Campbell A., Converse, P.E., Rodgers, W.L., 1976. The quality of American life. Russel Sage Foundation, New York.

    Google Scholar 

  37. Bechdolf, A., Klosterkötter, J., Hambrecht, M., Knost, B., Kuntermann, C., Schiller, C., Pukrop, R., 2003. Determinants of subjective quality of life in post acute patients with schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 253, 228–235.

    Article  PubMed  Google Scholar 

  38. Carpiniello B, Lai G, Pariante C M, et al., 1997. Symptoms, standards of living and subjective quality of life: a comparative study of schizophrenic and depressed out-patients. Acta Psychiatr. Scand. 96, 235–241.

    PubMed  CAS  Google Scholar 

  39. Reine, G., Lancon, C., Di Tucci, S., Sapin, C., Auquier, P., 2003. Depression and subjective quality of life in chronic phase schizophrenic patients. Acta Psychiatr. Scand. 108, 297–303.

    Article  PubMed  CAS  Google Scholar 

  40. Hafner, H., Maurer, K., Ruhrmann, S., Bechdolf A., Klosterkotter, J., Wagner, M., Maier, W., Bottlender, R., Möller, H.J., Gaebel, W., Wölwer, W., 2004. Are early detection and secondary prevention feasible? Facts and visions. Eur. Arch. Psychiatry Neurosci. 254, 117–128.

    Article  Google Scholar 

  41. Ruhrmann, S., Schultze-Lutter, F., Klosterkötter, J., 2003. Early detection and intervention in the initial prodromal phase of schizophrenia. Pharmacopsychiatry 36 (suppl 3), 162–167.

    Google Scholar 

  42. Yung, A.R., Phillips, L.J., McGorry, P.D. et al., 1998. Prediction of psychosis. Br. J. Psychiatry 172 (suppl. 33), 14–20.

    CAS  Google Scholar 

  43. Bechdolf, A., Knost, B., Kuntermann, C., Schiller, S., Hambrecht, M., Klosterkötter, J., Pukrop, R., 2004. A randomized comparison of group cognitive-behavioural therapy and group psychoeducation in patients with schizophrenia. Acta Psychiatr. Scand. 110, 21–28.

    Article  PubMed  CAS  Google Scholar 

  44. Pukrop, R., Möller, H.J., Steinmeyer E. M., 2000. Quality of life in psychiatry. A systematic contribution to construct validation and the development of the integrative assessment tool’’Modular system of quality of life.’’ Eur. Arch. Psychiatry Clin. Neurosci. 250, 120–132.

    Article  PubMed  CAS  Google Scholar 

  45. Maurer, K., Könnecke, R., Schultze-Lutter, F. Häfner, H., 2000. Early Recognition Inventory. Unpublished Manual and Instrument. Mannheim, Germany, 2000.

    Google Scholar 

  46. Maurer, K., Horrmann, F., Schmidt, M., Trendler, G., Hafner, H. 2004. The early recognition inventory: structure, reliability and initial results. Schizophr. Res. 67 (suppl), 34.

    Google Scholar 

  47. Kay S.R., 1987. The Positive and Negative Symptom Scale (PANSS) of schizophrenia. Schizophr. Bull. 13, 261–276.

    PubMed  CAS  Google Scholar 

  48. Wolthaus, J.E.D., Dingemans, P.M.A.J., Schene, A.H., Linzen, D.H., Knegtering, H., Holthausen, E.A.E., Cahn, W., Hijman, R., 2000. Component structure of the PANSS in patients with recent-onset schizophrenia and spectrum disorders. Psychopharmacology 150, 399–403.

    Article  PubMed  CAS  Google Scholar 

  49. Montgomery S, Asberg M., 1979. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 134, 382–389.

    CAS  Google Scholar 

  50. SPSS Statistical package for the social sciences, 2001. SPSS Release 11.0, SPSS, Chicago.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry and Psychotherapy, University of Cologne, Kerpenerstr, 6250937 Köln, Germany

    Andreas Bechdolf, Verena Veith, Ralf Pukrop & Joachim Klosterkötter

Authors
  1. Andreas Bechdolf
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Verena Veith
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ralf Pukrop
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Joachim Klosterkötter
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Associate Professor, Department of Psychiatry, Faculty of Medicine, Technion - Israel Institute of Technology, Haifa

    Michael S. Ritsner

  2. Director, Acute Department, Sha’ar Menashe, Mental Health Center, Israel

    Michael S. Ritsner

  3. Associate Editor, Quality of Life Research, Amsterdam, The Netherlands

    Michael S. Ritsner

  4. Professor Emeritus, Department of Psychiatry, Institute of Medical Science University of Toronto Chief of Psychiatry, Humber River Regional Hospital, Toronto

    A. George Awad

  5. Ontario President, The International Society of CNS, Clinical Trials and Methodology, Canada

    A. George Awad

Rights and permissions

Reprints and permissions

Copyright information

© 2007 springer

About this chapter

Cite this chapter

Bechdolf, A., Veith, V., Pukrop, R., Klosterkötter, J. (2007). Health Related Quality of Life in Subjects at Risk for a First Episode Of Psychosis. In: Ritsner, M.S., Awad, A.G. (eds) Quality of Life Impairment in Schizophrenia, Mood and Anxiety Disorders. Springer, Dordrecht. https://doi.org/10.1007/978-1-4020-5779-3_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-4020-5779-3_9

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-1-4020-5777-9

  • Online ISBN: 978-1-4020-5779-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation